No Picture
News

Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer’s Disease at AAIC 2021

CAMBRIDGE, Mass., July 29, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo) today announced that Biogen led a late-breaking presentation on the design of the first real-world observational Phase 4 study in Alzheimer’s disease called ICARE AD-US, at the Alzheimer’s Association International Conference (AAIC), being held… Click here to view original post… […]

No Picture
News

Immuneering Announces Pricing of Upsized Initial Public Offering

CAMBRIDGE, Mass., July 29, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced the pricing of its upsized initial public offering of 7,500,000 shares of Class… Click here to view original post… […]

No Picture
News

Heavy smokers with non-small cell lung cancer could benefit from certain immunotherapies

Knowing the current and previous smoking habits of patients with metastatic non-small cell lung cancer (NSCLC) could allow clinicians to make better informed treatment … Continue reading "Heavy smokers with non-small cell lung cancer could benefit from certain immunotherapies" Click here to view original post… […]

No Picture
News

Six more biotechs price public debuts just before the start of the weekend

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here. Another six biotechs priced IPOs on Thursday and Friday, joining this week’s big rush to Wall Street. Biotech companies have raised more than $11.7 billion so far this year, closing in on last year’s… Click here to view original post… […]

No Picture
News

Roche China CEO preps for a move to Merck KGaA while US Merck adds to C-suite; Succession plan finalized for EVPs retiring from Sanofi

Hong Chow → Beginning Oct. 1, Roche China CEO Hong Chow will be head of China & international for Merck KGaA’s healthcare business, a position that also encompasses Japan, Europe, Latin America, Asia-Pacific, the Middle East, Africa and Russia. The multi-pronged position… Click here to view original post… […]